Pulse Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | +47.0% | -47.4% | -40.3% | -100.0% | – | – | – | – | – | -100.0% | – | – | – | -50.0% | -100.0% | – | +207.0% | +51.9% | +8.2% | – | |
| – | -100.0% | – | +0.6% | -0.6% | -100.0% | – | +0.6% | -0.6% | +261.4% | -72.2% | -0.6% | +0.0% | – | – | +0.6% | -0.6% | – | – | -5.0% | +173.3% | +70.7% | -26.8% | +47.9% | +525.0% | -84.6% | -76.6% | +0.0% | -11.9% | +14.3% | -1.6% | -11.0% | +0.4% | +211.6% | -66.0% | -5.7% | +4.5% | +86.0% | -28.7% | -26.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -345.6% | – | – | – | – | – | – | – | – | – | – | – | -120.8% | – | – | – | -134.0% | – | – | – | – | +419.4% | – | |
| – | +3.9% | +2.5% | +23.3% | +40.2% | -10.5% | +10.9% | +24.7% | +27.2% | +0.8% | +15.0% | +8.5% | -2.3% | +6.4% | -6.2% | -5.0% | +18.7% | +6.6% | +22.1% | -17.7% | -13.4% | -12.4% | +19.6% | -19.4% | -17.2% | -9.3% | +42.3% | +14.9% | +11.6% | +4.4% | -13.6% | +7.3% | +6.5% | +38.4% | -3.3% | +17.2% | -5.7% | -4.1% | +15.2% | +34.8% | – | |
| – | -2.6% | +40.2% | +209.2% | +10.3% | +39.5% | -7.2% | -3.9% | +9.7% | -32.8% | +15.4% | +16.9% | +8.9% | +28.0% | -43.2% | -1.8% | +4.8% | -4.5% | +32.9% | -21.0% | +1.3% | +24.6% | -15.1% | -15.8% | -18.5% | -16.4% | +44.6% | -5.4% | +7.1% | +25.2% | -18.2% | +16.1% | +32.4% | +61.3% | -19.5% | +5.9% | +7.3% | +81.3% | -58.6% | +28.3% | – | |
| – | +1.6% | +13.9% | +92.2% | +21.0% | +17.4% | -1.2% | +6.6% | +17.0% | -16.7% | +14.9% | +11.9% | +2.7% | +16.4% | -14.2% | -5.0% | +13.7% | +6.6% | +34.7% | -20.1% | -4.6% | +6.3% | +12.0% | -23.0% | -25.6% | -22.6% | +28.4% | +7.0% | +10.0% | +11.4% | -17.7% | +13.7% | +16.5% | +48.4% | -10.9% | +10.9% | +0.8% | -10.8% | +6.6% | +32.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -4.9% | -100.0% | – | +144.6% | -13.9% | -100.0% | – | – | – | – | – | -73.1% | -57.1% | – | – | +353.5% | -98.3% | -33.3% | – | – | -22.2% | +3,128.6% | +77.0% | -62.5% | +128.7% | -10.1% | -22.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -300.0% | – | -163.2% | – | – | +107.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.